Hung David — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Hung David has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $46K.

Profile

David Hung is a prominent biopharmaceutical executive known for his leadership roles in the development of innovative therapies. He is the founder and CEO of Nuvation Bio Inc., a clinical-stage biopharmaceutical company focused on developing novel cancer therapies. Under his leadership, the company has made significant strides in advancing its pipeline of drug candidates.

Board memberships

• Nuvation Bio Inc.

Awards & honors

• Founded Nuvation Bio Inc.
• Led multiple successful clinical trials in oncology

Recent Transactions

Companies — Last 90 Days

• NovoCure Ltd (NVCR) — 2 filings, last 2026-06-05

Frequently Asked Questions

Who is Hung David?

David Hung is a prominent biopharmaceutical executive known for his leadership roles in the development of innovative therapies. He is the founder and CEO of Nuvation Bio Inc., a clinical-stage biopharmaceutical company focused on developing novel cancer therapies. Under his leadership, the company has made significant strides in advancing its pipeline of drug candidates.…

How many SEC Form 4 filings has Hung David submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Hung David been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($46K) across all tracked filings.

Where can I see all of Hung David's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week